Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 14 at 2:00 PM EDT

Register Free →

INTABIO, INC.

INTABIO, INC. is a federal contractor, registered under UEI MK59DMGJKYP4. It has been awarded $2,709,217 across 3 federal contracts. Primary work spans Unknown NAICS. Top awarding agencies include Department Of Health And Human Services, National Science Foundation, and Department Of Commerce (doc).

Contact Information

Registration and classification details

Registration

UEI Code

MK59DMGJKYP4

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

Key Performance Metrics

Awards Count

0

All time

Active

0

Currently performing

Completed

0

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award Analytics & Distribution

Awards by Agency
Awards by NAICS
Export
- Unknown NAICS$2.7M100%
Awards by Agency Over Time
Awards by Place of Performance

Compete with INTABIO, INC.

Track the contractors you bid against, and the work they win

Award history, agency mix, and NAICS coverage for INTABIO, INC.

AI-powered matching against your own capabilities and past performance

Teaming and subcontracting signals on every award

Automated alerts when a competitor wins in your market

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS

Open opportunities in INTABIO, INC.'s top NAICS codes and agencies

NAICS: 541715
SBIR / STTR
NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
Solicitation # PA-27-102
The NIH Small Business Technology Transfer (STTR) grant, solicitation PA-27-102, provides early-stage funding to United States small business concerns (SBCs) to conduct research and development for commercial products that support the NIH mission to enhance health and reduce illness. A mandatory requirement for this program is a formal collaboration between the SBC and a non-profit research institution. The program is structured in phases, with Phase I focusing on technical merit and feasibility, and Phase II advancing the project toward commercialization. Eligible applicants include U.S.-based, for-profit organizations with 500 or fewer employees that are more than 50 percent owned and controlled by U.S. citizens or permanent residents. The NIH also offers Fast-Track and Direct to Phase II options to accelerate the development timeline. Funding limits vary by the awarding Institute or Center, with Phase I budgets typically ranging from 400,000 to 700,000 dollars and Phase II budgets reaching up to 3,000,000 dollars. Applications are evaluated through a peer review system based on scientific merit, commercial potential, and the team's ability to execute the project, resulting in an overall impact score. While clinical trials are generally optional, specific institutes do not accept them under this NOFO. Recipients must adhere to strict compliance standards, including maintaining active SAM and UEI registrations, implementing cybersecurity incident reporting within 48 hours of discovery, and registering applicable clinical trials on ClinicalTrials.gov. Applications must be submitted via Grants.gov and tracked through eRA Commons.
Department of Health and Human Services

POSTED

4 months ago

DEADLINE

in 6 months
View Details
NAICS: 541715
SBIR / STTR
NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
Solicitation # PA-27-100
The NIH, CDC, and FDA Small Business Innovation Research (SBIR) Grant, solicitation PA-27-100, provides early-stage funding to United States small business concerns (SBCs) to conduct research and development for commercial products. The program is structured in phases, with Phase I focusing on technical merit and feasibility, and Phase II advancing the technology toward commercialization. Eligible applicants include for-profit U.S. businesses with no more than 500 employees. The funding opportunity accepts Phase I, Phase II, Direct to Phase II, and Fast-Track applications, with the latter two being specific to the NIH. Budget limits vary by participating institute, with Phase I awards typically ranging from 400,000 to 700,000 dollars and Phase II awards reaching up to 3,000,000 dollars. Applications are evaluated through the NIH peer review system based on scientific and technical merit, significance, environment, and relevance to program goals. Key requirements include maintaining active SAM.gov registration with a Unique Entity Identifier and adhering to strict cybersecurity incident reporting protocols, which require notification of breaches within 48 hours. While clinical trials are optional, they require a specific regulatory plan and registration on ClinicalTrials.gov. Certain institutes, including all FDA components and the National Center for Advancing Translational Sciences, do not accept clinical trials under this specific notice. The solicitation remains open for applications until April 6, 2027.
Department of Health and Human Services

POSTED

4 months ago

DEADLINE

in 6 months
View Details
NAICS: 541715
SBIR / STTR
SBIR/STTR Commercialization Readiness Pilot (CRP) Program (Parent SB1 Clinical Trial Optional)
Solicitation # PAR-27-098
The SBIR/STTR Commercialization Readiness Pilot (CRP) Program, solicitation PAR-27-098, is a funding opportunity provided by the National Institutes of Health (NIH) to help U.S.-based small business concerns transition technology from late-stage development to full commercialization. This program is specifically available to recipients of prior or active NIH SBIR or STTR Phase II or Phase IIB Strategic Breakthrough awards. The CRP supports activities that bridge the gap to market, including later-stage research and development, technical assistance, regulatory strategy, manufacturing scale-up, and clinical studies. Notably, the program allows for significant outsourcing to contract research organizations, provided the small business maintains a substantial role in project oversight and management. Eligible projects may have a maximum performance period of three years, with budget ceilings varying by the participating NIH Institute or Center, ranging from 500,000 dollars to 2 million dollars, or following SBA guidelines for certain institutes. Applications are evaluated through a peer review system focusing on scientific and technical merit, commercial potential, and relevance to program priorities. Required documentation includes a regulatory plan and a CRP progress report. While clinical trials are generally permitted, several NIH components, including the NHLBI and NIAID, do not accept them under this specific NOFO. Applicants must maintain active SAM registration, a CAGE code, and a Unique Entity Identifier to be eligible for award.
Department of Health and Human Services

POSTED

4 months ago

DEADLINE

in 6 months
View Details